Ex Vivo T-Cell Depletion of Mobilized Peripheral Blood Stem Cells Via CD34-Selection

Abroad (travel likely)Recruiting

Conditions

Stem Cell Transplant · Allogeneic

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Houston Methodist Hospital, Houston, Texas, United States
Contact: Study coordinator (Robert Krance, MD) · rakrance@txch.org · 832-824-4661
Contact: Study coordinator (Marlen Dinu) · mxdinu@txch.org · 832-824-4881
Texas Children's Hospital, Houston, Texas, United States
Contact: Study coordinator (Robert Krance, MD) · rakrance@txch.org · 832-824-4661
Contact: Study coordinator (Marlen Dinu) · mxdinu@txch.org · 832-824-4881

Study leads

Robert Krance, MD
Principal Investigator
Baylor College of Medicine

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Ruxolitinib and Chidamide Intensified Bu/CY Conditioning Regimen

Peripheral Blood Stem Cell Transplantation

Abroad (travel likely)RecruitingPHASE2

Beijing, China

Safety, Tolerability, and Efficacy of Enteral Nutrition Versus Standard of Care Nutrition in Hematopoietic Stem Cell Transplant Patients: A Pilot Study

Stem Cell

Abroad (travel likely)Recruiting

Houston, United States

A Clinical Study of Ultra-transplantation for the Treatment of Major Thalassemia Scheme

Stem Cell Transplantation

Abroad (travel likely)Recruiting

Kunming, China

Evaluation of CMV/EBV-CMI in Haploid HSCT

Hematopoietic Stem Cell Transplantation · Cytomegalovirus Infections · Epstein-Barr Virus Infections

Abroad (travel likely)Recruiting

Suzhou, China